- CA$12.69m
- CA$16.05m
Brief: Hemostemix Signs License Agreement With Aspire Health Science
Brief: Hemostemix Signs Manufacturing Agreement With Aspire Health Science
Brief: Hemostemix Receives Health Canada Clearance To Continue With Critical Limb Ischemia Clinical Trials
Brief: Hemostemix signs agreement with CRO service provider Topstone Research
Brief: Hemostemix completes conversion of subscription receipts and secured credit financing
Brief: Hemostemix Inc. Announces agreement to resolve all outstanding matters with Hemostemix (Asia) Corporation (HEMA)
Brief: Hemostemix announces CDN$4,400,000 senior secured debt financing
Brief: Drive Capital acquired C$1 mln convertible debenture of Hemostemix
Brief: Hemostemix announces reorganization
Brief: Hemostemix voids strategic alliance agreement with Hemostemix Asia Inc
Brief: Hemostemix says Criterium notified it has terminated master services agreement
Brief: Hemostemix announces non-brokered private placement